Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
New Drugs and Emerging Therapeutic Targets in the Endothelin Signaling Pathway and Prospects for Personalized Precision Medicine
Tracleer, INN- bosentan"
JPM | Free Full-Text | Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer's Disease
Frontiers | Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
CXCL10, a SSc Driver of Inflammation Lowered With Iloprost: Study| Scleroderma News
Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis - John W. McConnell, Yuen Tsang, Janis Pruett, William Drake
Submission Request Form for Pharmaceutical Manufacturers
Effects of bosentan, an edothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2 | Request PDF
Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arteri
Development of macitentan for the treatment of pulmonary arterial hypertension - Selej - 2015 - Annals of the New York Academy of Sciences - Wiley Online Library
Effects of bosentan, an edothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2 | Request PDF